ID   eFOP3-2
AC   CVCL_W547
DR   SKIP; SKIP000342
DR   Wikidata; Q54832077
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W548 ! eFOP3-4
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=24321451; DOI=10.1186/1750-1172-8-190; PMCID=PMC3892046;
RA   Matsumoto, Yoshihisa
RA   Hayashi, Yohei
RA   Schlieve, Christopher R.
RA   Ikeya, Makoto
RA   Kim, Hannah
RA   Nguyen, Trieu D.
RA   Sami, Salma
RA   Baba, Shiro
RA   Barruet, Emilie
RA   Nasu, Akira
RA   Asaka, Isao
RA   Otsuka, Takanobu
RA   Yamanaka, Shinya
RA   Conklin, Bruce R.
RA   Toguchida, Junya
RA   Hsiao, Edward C.
RT   "Induced pluripotent stem cells from patients with human
RT   fibrodysplasia ossificans progressiva show increased mineralization
RT   and cartilage formation.";
RL   Orphanet J. Rare Dis. 8:190.1-190.14(2013).
//